Hamid Hashemi-Moghaddam
Research Subjects
Hamid Hashemi-Moghaddam has a total of 202 co-authors. Here are the top co-authors by number of shared publications:
Hamid Madanchi
Department of Biotechnology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran
6 shared publications- Majid Mohammadhosseini
Department of Chemistry, College of Basic Sciences, Shahrood Branch, Islamic Azad University, Shahrood, Iran
6 shared publications Saeed Zavareh
School of Biology, Damghan University, 3671641167Damghan, Iran
6 shared publications- Abdorreza Mohammadi Nafchi
Food Technology Division, School of Industrial Technology, Universiti Sains Malaysia, Penang, Malaysia
4 shared publications Abolfazl Akbarzadeh
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3 shared publicationsKambiz Larijani
Department of Chemistry, Science and Research Branch, Islamic Azad University, Tehran, Iran
3 shared publications
Latest Publications
- 18 August 2025
- Published by Springer Nature in Journal of Fluorescence
- Vol. 35 (12) , 12747-12756
Assessment of Novel Core–Shell ZIF-8@poly L-DOPA Nanoparticles for Targeted Doxorubicin Delivery
Drug delivery systems using nanoparticles can deliver to tumor cells without affecting normal cells. In this study, a novel nano composite was synthesized by coupling abilities of ZIF-8 MOF and poly L-DOPA molecular imprinted polymer. Thus, a selective drug delivery system was designed for potential cancer treatment. A new nanocomposite, poly 3,4-dihydroxy-l-phenylalanine/ZIF-8 (L-DOPA/ZIF-8), was synthesized and used for targeted Doxorubicin delivery. The structural, morphological, and fluorescence properties of the synthesized samples were investigated by FT-IR, FE-SEM, and spectrofluorimetry. The investigation and characterization of the prepared ZIF-8@poly(dopa)/DOX sample indicated its layered and porous structure. The fluorescence emission spectrum showed that adding doxorubicin led to an increase in emission intensity, marking the successful loading of DOX. The safety and cytotoxicity of the prepared nanocomposite were investigated using the MTT method using the HEK293 cell line. The results show that the nanocomposite can be a biocompatible and safe nanocarrier in drug delivery applications. The drug release rate was investigated at two different pH levels, 7.4 and 5. The cumulative or total release of DOX from ZIF-8@poly(dopa)/DOX nanocomposite at pH 7.4 and 5.4 is 56.7 and 78.4%, respectively. Thus, this nanocarrier can be a suitable carrier for slow and controlled drug release into cancer cells.
- 18 August 2025
- Published by Springer Nature in Journal of Fluorescence
- Vol. 35 (12) , 12747-12756
Assessment of Novel Core–Shell ZIF-8@poly L-DOPA Nanoparticles for Targeted Doxorubicin Delivery
Drug delivery systems using nanoparticles can deliver to tumor cells without affecting normal cells. In this study, a novel nano composite was synthesized by coupling abilities of ZIF-8 MOF and poly L-DOPA molecular imprinted polymer. Thus, a selective drug delivery system was designed for potential cancer treatment. A new nanocomposite, poly 3,4-dihydroxy-l-phenylalanine/ZIF-8 (L-DOPA/ZIF-8), was synthesized and used for targeted Doxorubicin delivery. The structural, morphological, and fluorescence properties of the synthesized samples were investigated by FT-IR, FE-SEM, and spectrofluorimetry. The investigation and characterization of the prepared ZIF-8@poly(dopa)/DOX sample indicated its layered and porous structure. The fluorescence emission spectrum showed that adding doxorubicin led to an increase in emission intensity, marking the successful loading of DOX. The safety and cytotoxicity of the prepared nanocomposite were investigated using the MTT method using the HEK293 cell line. The results show that the nanocomposite can be a biocompatible and safe nanocarrier in drug delivery applications. The drug release rate was investigated at two different pH levels, 7.4 and 5. The cumulative or total release of DOX from ZIF-8@poly(dopa)/DOX nanocomposite at pH 7.4 and 5.4 is 56.7 and 78.4%, respectively. Thus, this nanocarrier can be a suitable carrier for slow and controlled drug release into cancer cells.
- 7 November 2024
- Published by Springer Nature
- p. 373-396
Applications of MIPs in Separation Research: From Solid Phase Extraction to Selective Membrane Filters
- 7 November 2024
- Published by Springer Nature
- p. 373-396
Applications of MIPs in Separation Research: From Solid Phase Extraction to Selective Membrane Filters
- 29 March 2024
- Published by Elsevier
- p. 117-133
Polymer-coated magnetic nanoparticles for cancer therapy
- 29 March 2024
- Published by Elsevier
- p. 117-133
Polymer-coated magnetic nanoparticles for cancer therapy
- 29 March 2024
- Published by Elsevier
Contributors
- 7 November 2023
- Vol. 18 (1) , 45-53
An Experimental Study on The Oxidative Status and Inflammatory Levels of A Rat Model of Polycystic Ovary Syndrome Induced by Letrozole and A New High-Fat Diet.
Although there are numerous animal models of polycystic ovary syndrome (PCOS), they often fail to accurately replicate the reproductive and metabolic phenotypes associated with PCOS. The objective of this study is to assess oxidative status and inflammatory levels in a rat model of PCOS subjected to a new high-fat diet (HFD) in combination with letrozole. In this experimental study, mature, six-week-old female Sprague-Dawley rats (n=20) were divided into four groups: control (standard diet); letrozole (letrozole plus a standard diet); HFD; and letrozole+HFD. After 16 weeks, the rats underwent vaginal smear analysis, measurement of hormonal and lipid profiles, and an oral glucose tolerance test (OGTT). Ovarian tissue morphology, oxidative parameters, and inflammatory status were evaluated. The experimental groups exhibited anoestrus profiles in the vaginal smears and abnormal ovarian morphology, which was not observed in the control group. Steroid hormone levels were significantly higher in the letrozole+HFD group compared to the other groups (P=0.00). The experimental groups also showed abnormal glucose levels and lipid metabolism. The relative expression levels of inflammatory genes were significantly elevated in the experimental groups compared to the control group (P=0.00), and the letrozole+HFD group exhibited the highest expression level (P=0.00). The HFD, letrozole, and letrozole+HFD groups demonstrated significantly increased levels of malondialdehyde (MDA) and reactive oxygen species (ROS), while the levels of enzymatic antioxidants were significantly reduced compared to the control group (P=0.00). The combination of a new HFD and letrozole treatment induces inflammation and oxidative stress (OS) in a rat model of PCOS. This model accurately exhibits abnormal metabolic phenotypes and disruptions in hormonal profiles associated with PCOS.
- 7 November 2023
- Vol. 18 (1) , 45-53
An Experimental Study on The Oxidative Status and Inflammatory Levels of A Rat Model of Polycystic Ovary Syndrome Induced by Letrozole and A New High-Fat Diet.
Although there are numerous animal models of polycystic ovary syndrome (PCOS), they often fail to accurately replicate the reproductive and metabolic phenotypes associated with PCOS. The objective of this study is to assess oxidative status and inflammatory levels in a rat model of PCOS subjected to a new high-fat diet (HFD) in combination with letrozole. In this experimental study, mature, six-week-old female Sprague-Dawley rats (n=20) were divided into four groups: control (standard diet); letrozole (letrozole plus a standard diet); HFD; and letrozole+HFD. After 16 weeks, the rats underwent vaginal smear analysis, measurement of hormonal and lipid profiles, and an oral glucose tolerance test (OGTT). Ovarian tissue morphology, oxidative parameters, and inflammatory status were evaluated. The experimental groups exhibited anoestrus profiles in the vaginal smears and abnormal ovarian morphology, which was not observed in the control group. Steroid hormone levels were significantly higher in the letrozole+HFD group compared to the other groups (P=0.00). The experimental groups also showed abnormal glucose levels and lipid metabolism. The relative expression levels of inflammatory genes were significantly elevated in the experimental groups compared to the control group (P=0.00), and the letrozole+HFD group exhibited the highest expression level (P=0.00). The HFD, letrozole, and letrozole+HFD groups demonstrated significantly increased levels of malondialdehyde (MDA) and reactive oxygen species (ROS), while the levels of enzymatic antioxidants were significantly reduced compared to the control group (P=0.00). The combination of a new HFD and letrozole treatment induces inflammation and oxidative stress (OS) in a rat model of PCOS. This model accurately exhibits abnormal metabolic phenotypes and disruptions in hormonal profiles associated with PCOS.
- 8 September 2023
- Published by Springer Nature in Journal of Food Measurement and Characterization
- Vol. 17 (6) , 6405-6412
Application of lysine imprinted polymer as carbon dioxide colorimetric indicators for food packaging
- 8 September 2023
- Published by Springer Nature in Journal of Food Measurement and Characterization
- Vol. 17 (6) , 6405-6412
Application of lysine imprinted polymer as carbon dioxide colorimetric indicators for food packaging
- 21 June 2023
- Published by Springer Nature in Journal of Polymer Research
- Vol. 30 (7) , 1-9
Graphene quantum dots coated cationic polymer for targeted drug delivery and imaging of breast cancer
- 21 June 2023
- Published by Springer Nature in Journal of Polymer Research
- Vol. 30 (7) , 1-9
Graphene quantum dots coated cationic polymer for targeted drug delivery and imaging of breast cancer
- 7 December 2022
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 20 (1) , 101-117
Synergistic Effect Evaluation of Magnetotherapy and a Cationic–Magnetic Nanocomposite Loaded with Doxorubicin for Targeted Drug Delivery to Breast Adenocarcinoma
This work investigates the synergistic effect of magnetotherapy and a novel cationic-magnetic drug delivery system on inhibiting breast cancer cell growth and other tissues. First, super-paramagnetic magnetite (Fe3O4) nanoparticles were coated with doxorubicin-imprinted poly(methacrylic acid-co-diallyl dimethylammonium chloride) [Fe3O4/poly(MAA-DDA)]. The cationic-magnetic nanocomposite (CMC) was characterized using XRD, FT-IR, VSM, TGA, TEM, FESEM, EDS, DLS, and BET. In vitro analyses, including drug release kinetics, cytotoxicity, and hemolytic assays, confirmed this novel CMC's good drug release profile and biocompatibility. Finally, in vivo experiments on BALB/c mice were designed to evaluate the synergistic effect of magnetotherapy on targeted drug delivery using the CMC. In vivo fluorescence imaging evaluated the drug distribution in different tissues of mice. Tumor volume evaluation demonstrated the efficiency of the CMC and magnetotherapy in preventing tumor growth; the two techniques significantly reduced tumor volume. Histopathological analysis proved that applying magnetotherapy in conjunction with the cationic-magnetic drug delivery system significantly prevented tumor cell proliferation and increased apoptosis with limited impact on other tissues. Also, Dox and Fe concentrations in different tissues confirmed the efficient drug delivery to tumor cells.
- 7 December 2022
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 20 (1) , 101-117
Synergistic Effect Evaluation of Magnetotherapy and a Cationic–Magnetic Nanocomposite Loaded with Doxorubicin for Targeted Drug Delivery to Breast Adenocarcinoma
This work investigates the synergistic effect of magnetotherapy and a novel cationic-magnetic drug delivery system on inhibiting breast cancer cell growth and other tissues. First, super-paramagnetic magnetite (Fe3O4) nanoparticles were coated with doxorubicin-imprinted poly(methacrylic acid-co-diallyl dimethylammonium chloride) [Fe3O4/poly(MAA-DDA)]. The cationic-magnetic nanocomposite (CMC) was characterized using XRD, FT-IR, VSM, TGA, TEM, FESEM, EDS, DLS, and BET. In vitro analyses, including drug release kinetics, cytotoxicity, and hemolytic assays, confirmed this novel CMC's good drug release profile and biocompatibility. Finally, in vivo experiments on BALB/c mice were designed to evaluate the synergistic effect of magnetotherapy on targeted drug delivery using the CMC. In vivo fluorescence imaging evaluated the drug distribution in different tissues of mice. Tumor volume evaluation demonstrated the efficiency of the CMC and magnetotherapy in preventing tumor growth; the two techniques significantly reduced tumor volume. Histopathological analysis proved that applying magnetotherapy in conjunction with the cationic-magnetic drug delivery system significantly prevented tumor cell proliferation and increased apoptosis with limited impact on other tissues. Also, Dox and Fe concentrations in different tissues confirmed the efficient drug delivery to tumor cells.
- 1 October 2022
- Published by Maad Rayan Publishing Company in Archives of Hygiene Sciences
- Vol. 11 (4) , 272-278
Evaluation of Chemical Composition of Vaccaria oxyodontha Boiss Plant Essential Oils and Antioxidant and Antibacterial Effects on Gram-Negative and Gram-Positive Bacteria
Background & Aims: Caryophyllaceae is a large family of about 2200 herbaceous or subshrub species. Vaccaria oxyodontha Boiss is of the family Caryophyllaceae. This plant grows as a weed in agricultural land of sugarcane, wheat, barley, forage, and summer crops such as sugar beet, potato, cotton, and onion. All parts of the V. oxyodontha Boiss plant, especially its root, contain a type of saponin, which shows its medicinal value. According to traditional Iranian medicine, this plant is a blood purifier and has anti-infective, utilized for cough, anti-rheumatism, and anti-inflammatory properties. This study first aimed to investigate the chemical composition of V. oxyodontha Boiss essential oil (EO) and the antioxidant and antibacterial properties of the hydroalcoholic extract of this plant on gram-positive and gram-negative bacteria. Materials and Methods: In this study, EOs were extracted from the aerial parts of V. oxyodontha Boiss using the combination of hydrodistillation and microwave-assisted hydrodistillation methods. Then, the antioxidant properties and antibacterial activity of the extract were evaluated, and the chemical compositions of the EOs of V. oxyodontha Boiss were determined using gas chromatography-mass spectroscopy (GC-MS). The extract’s antioxidant activity was studied by the 2,2-diphenyl-1- picrylhydrazyl-hydrate (DPPH) method. In addition, the plant antimicrobial effects were investigated by the agar disk diffusion method, and minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined as well. Finally, the antibacterial activity of the mentioned plant was compared with the antibiotic discs of gentamicin (10 mg) and vancomycin (30 mg). Results: The major compounds in the EOs were 2-Pentadecanone,6,10,14-trimethyl (10.52%) and 1,2-Benzenedicarboxylic acid (19.27%). Half maximal inhibitory concentration (IC50) of V. oxyodontha Boiss was 0.49 µg/mL, which was higher than that of vitamin C (IC50 value of 0.56 µg/mL). Further, MIC and MBC for the V. oxyodontha Boiss extract against Staphylococcus aureus and Escherichia coli were 62.5 and 125 mg/mL, as well as 31.25 and 62.5 mg/mL, respectively. Conclusion: The results of GC-MS demonstrated that the EO of the V. oxyodontha Boiss plant contains antioxidant and antibacterial compounds. Its antioxidant properties are higher than vitamin C. The highest diameter of the inhibition zone caused by the methanol extract of the V. oxyodontha Boiss plant was against S. aureus and E. coli (23.7±0.29 mm and 15.65±0.33 mm, respectively). Compared with the antibiotics vancomycin, the Vaccaria oxyodontha Boiss represented a stronger inhibitory effect in the inhibition of S. aureus (P<0.05).
- 1 October 2022
- Published by Maad Rayan Publishing Company in Archives of Hygiene Sciences
- Vol. 11 (4) , 272-278
Evaluation of Chemical Composition of Vaccaria oxyodontha Boiss Plant Essential Oils and Antioxidant and Antibacterial Effects on Gram-Negative and Gram-Positive Bacteria
Background & Aims: Caryophyllaceae is a large family of about 2200 herbaceous or subshrub species. Vaccaria oxyodontha Boiss is of the family Caryophyllaceae. This plant grows as a weed in agricultural land of sugarcane, wheat, barley, forage, and summer crops such as sugar beet, potato, cotton, and onion. All parts of the V. oxyodontha Boiss plant, especially its root, contain a type of saponin, which shows its medicinal value. According to traditional Iranian medicine, this plant is a blood purifier and has anti-infective, utilized for cough, anti-rheumatism, and anti-inflammatory properties. This study first aimed to investigate the chemical composition of V. oxyodontha Boiss essential oil (EO) and the antioxidant and antibacterial properties of the hydroalcoholic extract of this plant on gram-positive and gram-negative bacteria. Materials and Methods: In this study, EOs were extracted from the aerial parts of V. oxyodontha Boiss using the combination of hydrodistillation and microwave-assisted hydrodistillation methods. Then, the antioxidant properties and antibacterial activity of the extract were evaluated, and the chemical compositions of the EOs of V. oxyodontha Boiss were determined using gas chromatography-mass spectroscopy (GC-MS). The extract’s antioxidant activity was studied by the 2,2-diphenyl-1- picrylhydrazyl-hydrate (DPPH) method. In addition, the plant antimicrobial effects were investigated by the agar disk diffusion method, and minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined as well. Finally, the antibacterial activity of the mentioned plant was compared with the antibiotic discs of gentamicin (10 mg) and vancomycin (30 mg). Results: The major compounds in the EOs were 2-Pentadecanone,6,10,14-trimethyl (10.52%) and 1,2-Benzenedicarboxylic acid (19.27%). Half maximal inhibitory concentration (IC50) of V. oxyodontha Boiss was 0.49 µg/mL, which was higher than that of vitamin C (IC50 value of 0.56 µg/mL). Further, MIC and MBC for the V. oxyodontha Boiss extract against Staphylococcus aureus and Escherichia coli were 62.5 and 125 mg/mL, as well as 31.25 and 62.5 mg/mL, respectively. Conclusion: The results of GC-MS demonstrated that the EO of the V. oxyodontha Boiss plant contains antioxidant and antibacterial compounds. Its antioxidant properties are higher than vitamin C. The highest diameter of the inhibition zone caused by the methanol extract of the V. oxyodontha Boiss plant was against S. aureus and E. coli (23.7±0.29 mm and 15.65±0.33 mm, respectively). Compared with the antibiotics vancomycin, the Vaccaria oxyodontha Boiss represented a stronger inhibitory effect in the inhibition of S. aureus (P<0.05).